Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage.
Angelica CanossiAnna AureliTiziana Del BeatoPiero RossiLuana FranceschilliFlavio De SanctisPierpaolo SileriNicola di LorenzoOreste BuonomoDavide LauroAdriano VendittiGiuseppe SconocchiaPublished in: Journal of translational medicine (2016)
Our data suggest that the analysis of aKIRs and KIR2DL2 gene and CD16A-48H may be of interest for the identification of individuals at reduced and increased genetic risk of CRC, respectively.